Parsons Capital Management’s China Pharma Holdings CPHI Stock Holding History

Parsons Capital Management’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20	Closed	-$2K	–	317
2019 Q4	$2K	Hold	20	–	–	﹤0.01%	349
2019 Q3	$2K	Hold	20	–	–	﹤0.01%	344
2019 Q2	$3K	Hold	20	–	–	﹤0.01%	351
2019 Q1	$3K	Hold	20	–	–	﹤0.01%	346
2018 Q4	$3K	Hold	20	–	–	﹤0.01%	332
2018 Q3	$2K	Hold	20	–	–	﹤0.01%	356
2018 Q2	$2K	Hold	20	–	–	﹤0.01%	355
2018 Q1	$3K	Hold	20	–	–	﹤0.01%	354
2017 Q4	$2K	Hold	20	–	–	﹤0.01%	363
2017 Q3	$2K	Hold	20	–	–	﹤0.01%	358
2017 Q2	$2K	Hold	20	–	–	﹤0.01%	352
2017 Q1	$3K	Hold	20	–	–	﹤0.01%	341
2016 Q4	$3K	Hold	20	–	–	﹤0.01%	337
2016 Q3	$2K	Buy	+20	New	+$2.56K	﹤0.01%	332
2016 Q2	–	Sell	-20	Closed	-$2K	–	320
2016 Q1	$2K	Hold	20	–	–	﹤0.01%	326
2015 Q4	$2K	Hold	20	–	–	﹤0.01%	326
2015 Q3	$2K	Hold	20	–	–	﹤0.01%	338
2015 Q2	$4K	Buy	+20	New	+$3.44K	﹤0.01%	347

Other funds holding CPHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parsons Capital Management's CPHI Position: Q1 2020 in Review

Parsons Capital Management sold out of China Pharma Holdings (CPHI) in Q1 2020, closing a stake of 20 shares — an estimated $2K sold.

Parsons Capital Management first reported a position in CPHI in Q2 2015 and held it in 18 quarters. The position peaked at $4K in Q2 2015. 3 funds tracked by Wall St. Rank hold CPHI as of Q1 2020.

Parsons Capital Management reported no remaining China Pharma Holdings position as of Q1 2020 after selling out during the quarter.
Parsons Capital Management sold 20 China Pharma Holdings shares in Q1 2020, an estimated $2K.
Parsons Capital Management first reported a position in China Pharma Holdings in Q2 2015 and held it in 18 quarters.
Parsons Capital Management's China Pharma Holdings position peaked at $4K in Q2 2015.
3 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2020.

Based on Parsons Capital Management's 13F filing for Q1 2020, filed 5 May 2020.